MQI-201

N/A

Report date: 2026/03/30 20:02:02

First In Class

Base Information

Drug NameMQI-201

Drug Alias NameMQI-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAnti-Transient receptor potential cation channel subfamily V member 6

TargetsTransient receptor potential cation channel subfamily V member 6

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMabqi SAS

China Registration ClassN/A

Active CompaniesMabqi SAS

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A